Preeclampsia, a new perspective in 2011

Middle East Journal of Anesthesiology

Volumn 21, Issue 2, 2011, Pages 207-215

  Sidani, Marwa ^a   Siddik Sayyid, Sahar M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; GENERAL ANESTHESIA; HUMAN; NERVE BLOCK; OBSTETRIC ANESTHESIA; PREECLAMPSIA; PREGNANCY; RISK FACTOR;

ANESTHESIA, GENERAL; ANESTHESIA, OBSTETRICAL; FEMALE; HUMANS; NERVE BLOCK; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84857287638     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. DULEY L: The management of preeclampsia. The Obstetrician and Gynaecologist; 2000, 2:45-48.
2. DULEY L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol; 2009, 33:130-137.
3. KHAN KS, WOJDYLA D, SAY L, GÜLMEZOGLU AM, VAN LOOK PF: WHO analysis of causes of maternal death: a systematic review. Lancet; 2006, 367:1066-74.
4. BROWN MA, LINDHEIMER MD, DE SWIET M, VAN ASSCHE A, MOUTQUIN JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy. Hypertension in Pregnancy; 2001, 20:9-14.
5. JOY L HAWKIN: Anesthetic Management of the Preeclamptic patient. Crash; 2010.
6. Working group report on high blood pressure in pregnancy: Report of the National High Blood Pressure Education program. Am J Obstet Gynecol; 2000, 183:181-192.
7. GANGARAM R, OJWANG PJ, MOODLEY J, MAHARAJ A: The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy. Hypertension in Pregnancy; 2005, 24:117-123.
8. AIROLDI J, WEINSTEIN L: Clinical significance of proteinuria in pregnancy. Obstet Gynecol Surv; 2007, 62:117-124.
9. RATH W, FISCHER T: The diagnosis and treatment of hypertensive disorders of pregnancy: New findings for the antenatal and inpatient care. Dtsch Arztebl Int; 2009, 106:733-738.
10. KARUMANCHI SA, LINDHEIMER MD: Advances in Understanding of eclampsia. Current Hypertension Reports; 2008, 10:305-312.
11. LINDHEIMER MD, KANTER D: Interpreting abnormal proteinuria in pregnancy. Obstet Gynecol; 2010, 115:365-375.
12. KARUMANCHI SA, Kee-Hak Lim, Phyllis August, Susan M Ramin, Vanessa A Barss: Pathogenesis of preeclampsia. Uptodate; 2011.
13. BATES SM, GREER JA, PABINGER J, SOTAER S, HIRSCH J: Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. Chest; 2008, 133:844-88.
14. MOSTELLO D, KALLOGJERI D, TUNGSIRIPAT R, LEET T: Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol; 2008, 199:55.
15. MARTIN JW, ROSE CH, BRIERY CM: Understanding and managing HELLP-syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol; 2006, 195:914-934.
16. PAPAGEORGHIOU AT: Predicting and presenting preeclampsia-where to next? Ultrasound Obstet Gynecol; 2008, 31:367-370.
17. CNOSSEN JS, MORRIS RK, TER RIET G, MOL BW, VAN DER POST JA, COOMARASAMY A, ZWINDERMAN AH, ROBSON SC, BINDELS PJ, KLEIJNEN J, KHAN KS: Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ; 2008, 178:701-711.
18. LEVINE RJ, LAM C, QIAN C, YU KF, MAYNARD SE, SACHS BP, SIBAI BM, EPSTEIN FH, ROMERO R, THADHANI R, KARUMANCHI SA: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New Engl J Med; 2006, 355:992-1005.
19. SCAZZOCCHIOA E, FIGUERASA F: Contemporary prediction of preeclampsia. Current Opinion in Obstetrics & Gynecology; 2011, 23:65-71.
20. AQUILINA J, THOMPSON O, THILAGANATHAN B, HARRINGTON K: Improved early prediction of preeclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Ultrasound Obstet Gynecol; 2001, 17:477-484.
21. SPENCER K, COWANS NJ, CHEFETZ I: Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of preeclampsia. Prenat Diagn; 2007, 27:258-263.
22. SIBAI BM, DEKKER G, KUPFERMINC M: Pre-eclampsia. Lancet; 2005, 365:785-799.
23. HOFMEYR GJ, DULEY L, ATALLAH A: Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. Evid Based Med; 2008, 13:83.
24. DULEY L, Henderson-Smart DJ, MEHER S, KING JF: Antiplatelet agents for preventing pre-eclampsia and its complications (review). Cochrane Database Syst Rev; 2007, 2 CD 004659.
25. REY E, GARNEAU P, GAUTHIER R, LEDUC N, MICHON F, MORIN C, et al: Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women with and without thrombophilia: a pilot randomised controlled trial. J Thromb Haemost; 2009, 7:58-64.
26. SIBAI BM: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol; 2003, 102(1):181-192.
27. Magpie Trial Collaborative Group: Do women with preeclampsia, and their babies, benefit from magnesium sulphate?. Lancet; 2002, 359:1877-1890.
28. SIBAI BM: Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol; 2004, 190:1520-6.
29. VON DADELSZEN P, MAGEE LA: Antihypertensive medications in management of gestational hypertension-preeclampsia. Clin Obstet Gynecol; 2005, 8:441-459.
30. VISALYAPUTRA S, RODANANT O, SOMBOONVIBOON W, TANTIVITAYATAN K, THIENTHONG S, SAENGCHOTE W: Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: A prospective randomized, multicenter study. Anesth Analg; 2005, 101(3):862-868.
31. AYA AG, MANGIN R, VIALLES N, et al: Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: A prospective cohort comparison. Anesth Analg; 2003, 97:867-872.
32. AYA AG, VIALLES N, TANOUBI I, et al: Spinal anesthesia-induced hypotension: A risk comparison between patients with severe preeclampsia and health women undergoing preterm cesarean delivery. Anesth Analg; 2005, 101:869-875.
33. DYER, MICHAEL F: Maternal Hemodynamic Monitoring in Obstetric Anesthesia. Anesthesiology; 2008, 109:765-767.
34. TURNER J: Diagnosis and management of preeclampsia: an update. International Journal of Women's Health; 2010, 2:327-337.
35. SANTOS AC, BIRNBACH DJ: Spinal anesthesia for cesarean delivery in severely preeclamptic women: Don't throw out the baby with the bathwater!. Anesthesia Analgesia; 2005, 101:859-861.
36. NGAN KEE WD, KHAW KS, MA KC, WONG AS, LEE BB, NG FF: Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery. Anesthesiology; 2006, 104:14-20.
37. VIKSE BE, IRGENS LM, LEIVESTAD T, SKJæRVEN R, IVERSEN BM: Preeclampsia and the Risk of End-Stage Renal Disease. Engl J Med; 2008, 359:800-809.
38. BELLAMY L, CASAS JP, HINGORANI AD, WILLIAMS DJ: Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ; 2007, 335:974.
39. AUKES AM, WESSEL I, DUBOIS AM, AARNOUDSE JG, ZEEMAN GG: Self-reported cognitive functioning in formerly eclamptic women. American Journal of Obst & Gyn; 2007, 197:365.